4-Methoxy-6-methyl-2-(methylthio)pyrimidine, 95.0%, 250mg

RuCl[(S,S)-Fsdpen](p-cymene)>90%(NMR)1g

4-(Benzylamino)phenol, 95.0%, 1g

1-Bromo-3-(1,3-dioxolan-2-yl)-4-methoxybenzene, 97.0%, 1g

1,1',3',5'-tetramethyl-1H,1'H-3,4'-bipyrazole-5-carboxylic acid, 95.0%, 250mg

3-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)benzonitrile, 95.0%, 1g

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98.0%, 25g

N-(4-methoxybenzyl)pyridazin-3-amine, 98%, 100mg

5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyrazine, 96%, 1g

N-(4-methylpyrimidin-2-yl)thiourea, 95.0%, 1g

Screw vials conical sterile, 1.5 ml, 1000 Piece(s)

5-(3-Bromophenyl)-1H-imidazole, 95.0%, 1g

2-Acetylphenylboronic acid pinacol ester, 95+%, 1g